The Lancet has just published previously reported data from the European Randomized Study of Screening for Prostate Cancer (the ERSPC trial) at 13 years of follow-up. These data were first reported earlier this year at the annual meeting of the EAU, and we commented then on the significance of these data. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: ERSPC, mortality, PSA, risk, screening | 4 Comments »
So one of the presentations given at the recent EAU meeting in Stockholm was an update, by Dr. Jonas Hugosson, at a median 13 years of follow-up, from the European Randomized Study of Screening for Prostate Cancer (ERSPC) — and there is some good news, but maybe not enough to get carried away by … yet. READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: ERSPC, Europe, risk, screening, testing | 6 Comments »
A new article by Australian researchers in the Journal of the National Cancer Institute has suggested that the more widespread use of androgen deprivation therapy (ADT) among unscreened patients (controls) in the ERSPC and the Göteborg studies may have substantially affected patient mortality data in these trials. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: bias, ERSPC, results, screening, Treatment | 6 Comments »
A new article in the New England Journal of Medicine this week has updated the prostate cancer-specific and all-cause (overall) mortality data from the European Randomized Study of Screening for Prostate Cancer (ERSPC). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: ERSPC, mortality, outcome, screening | 77 Comments »
A newly published, retrospective analysis of mortality data from participants in the European Randomized Study of Screening for Prostate Cancer (ERSPC) trial suggests the possibility that men diagnosed with clinical symptoms of prostate cancer are at higher risk for non-prostate cancer-related mortality than men diagnosed through a screening protocol. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: ERSPC, mortality, non-prostate cancer-specific, screening | Leave a comment »
A newly published study has suggested that the risk calculator based on data from the European Randomized Study of Screening for Prostate Cancer (ERSPC-RC) may be a better predictor of risk for prostate cancer in Canadians that the risk calculator based on the US-based Prostate Cancer Prevention Trial (PCPT-RC). … READ MORE …
Filed under: Diagnosis, Risk | Tagged: calculator, ERSPC, PCPT, risk | Leave a comment »
An unexpected publication in the urology literature is an article analyzing the ways in which selected major media reported on the results of the Prostate Lung Colorectal Ovarian Cancer (PLCO) and the European Randomized Study of Screening for Prostate Cancer (ERSPC) trials after their publication in the New England Journal of Medicine in early 2009. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: ERSPC, media, PLCO, screening | 2 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 